Author :   V.E Orel

USE OF MACHANOCHEMICALLY ACTIVATED CHARGED NANOPARTICLES OF DOXORUBICIN AS A FACTOR LIMITING COMPLICATIONS IN POLYCHEMOTHERAPY OF PATIENTS WITH MALIGNANT LYMPHOMAS

Authors:S.A. Sivkovich V.E Orel N.N. Dzyatkovskaya 2019-05-07 4